Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Amphastar Pharmaceuticals Inc (AMPH) – Amphastar Pharmaceuticals Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

AMPH trades at $19.00, down 20.93% over 24 hours, reflecting a sharp sell-off following recent earnings misses. The technical outlook is bullish based on moving averages, but oscillators are neutral, with RSI-6 at 90.27 indicating potential overbought conditions. Fundamentally, the company maintains solid profitability with a 47.34% gross margin and an 11% net income margin, though Q1 2026 EPS of $0.42 missed expectations of $0.70. Analyst consensus remains positive with a $26.25 price target, but recent earnings underperformance and margin pressures from 2025 to 2026 pose concerns.
The stock presents a value opportunity with a low P/E of 11.45 and P/B of 1.08, but faces headwinds from declining net income margins and consecutive earnings misses. Upside potential exists if the company meets future earnings estimates and stabilizes margins, but investors must weigh the risk of continued operational challenges against the current discounted valuation.
Read full analysis

Key Stats

  • Market Cap
    $837.77M
  • Sector
    Health
  • 3M Drawdown
    -36.57%
  • Enterprise Value
    $1.23B
  • Dividend Yield
    -
  • Typical Hold Time
    3 days
$18.59
52W Low: $18.18
13 Mar 2026
52W High: $30.81
02 Sep 2025

Amphastar Pharmaceuticals Inc (AMPH) is currently valued at a market capitalization of $837.77M, with an enterprise value of $1.23B. Over the past 52 weeks, Amphastar Pharmaceuticals Inc has traded between a low of $18.18 and a high of $30.81, highlighting its annual price range. Over the past three months, Amphastar Pharmaceuticals Inc has recorded a drawdown of -36.57%, reflecting recent price volatility. On average, investors hold Amphastar Pharmaceuticals Inc for approximately 3 days, indicating typical investor behavior on the platform.

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.


Technical Indicators
|
|
|
Overall Summary
Bearish (19)Neutral (3)Bullish (5)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $837.77M
  • Sector
    Health
  • 3M Drawdown
    -36.57%
  • Enterprise Value
    $1.23B
  • Dividend Yield
    -
  • Typical Hold Time
    3 days
$18.59
52W Low: $18.18
13 Mar 2026
52W High: $30.81
02 Sep 2025

Amphastar Pharmaceuticals Inc (AMPH) is currently valued at a market capitalization of $837.77M, with an enterprise value of $1.23B. Over the past 52 weeks, Amphastar Pharmaceuticals Inc has traded between a low of $18.18 and a high of $30.81, highlighting its annual price range. Over the past three months, Amphastar Pharmaceuticals Inc has recorded a drawdown of -36.57%, reflecting recent price volatility. On average, investors hold Amphastar Pharmaceuticals Inc for approximately 3 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!